Kevin E. Weddington

Array ( [id] => 5953960 [patent_doc_number] => 20110034421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'CREATINE ORAL SUPPLEMENTATION USING CREATINE HYDROCHLORIDE SALT' [patent_app_type] => utility [patent_app_number] => 12/909377 [patent_app_country] => US [patent_app_date] => 2010-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6701 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034421.pdf [firstpage_image] =>[orig_patent_app_number] => 12909377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033552 [patent_doc_number] => 20110082201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'Use of L-Butylphthalide in the Manufacture of Medicaments for Prevention and Treatment of Cerebral Infarct' [patent_app_type] => utility [patent_app_number] => 12/908520 [patent_app_country] => US [patent_app_date] => 2010-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4495 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082201.pdf [firstpage_image] =>[orig_patent_app_number] => 12908520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713334 [patent_doc_number] => 08399474 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Method of restoring the incretin effect' [patent_app_type] => utility [patent_app_number] => 12/906740 [patent_app_country] => US [patent_app_date] => 2010-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4924 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12906740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807856 [patent_doc_number] => 08445508 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'Method of restoring the incretin effect' [patent_app_type] => utility [patent_app_number] => 12/906735 [patent_app_country] => US [patent_app_date] => 2010-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4928 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12906735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144543 [patent_doc_number] => 20110130356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'MORPHINE AND MORPHINE PRECURSORS' [patent_app_type] => utility [patent_app_number] => 12/904373 [patent_app_country] => US [patent_app_date] => 2010-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 25399 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130356.pdf [firstpage_image] =>[orig_patent_app_number] => 12904373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8749541 [patent_doc_number] => 08415374 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-09 [patent_title] => 'Combinations of hepatitis C virus inhibitors' [patent_app_type] => utility [patent_app_number] => 12/899840 [patent_app_country] => US [patent_app_date] => 2010-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8033 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12899840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199885 [patent_doc_number] => 08187590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Probiotic, lactic acid-producing bacteria and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/897604 [patent_app_country] => US [patent_app_date] => 2010-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19520 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/187/08187590.pdf [firstpage_image] =>[orig_patent_app_number] => 12897604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8382309 [patent_doc_number] => 20120225934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'INCLUSION COMPLEX OF DEOXYPODOPHYLLOTOXIN OF CYCLODEXTRIN, PREPARATION METHOD, USE FOR TREATMENT OF CANCER THEREOF' [patent_app_type] => utility [patent_app_number] => 13/502092 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6357 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6150036 [patent_doc_number] => 20110021631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Method of preparing stabilized pharmaceutical compositions comprising active ingredients susceptible to conversion to alternate polymorph forms' [patent_app_type] => utility [patent_app_number] => 12/878562 [patent_app_country] => US [patent_app_date] => 2010-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5731 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021631.pdf [firstpage_image] =>[orig_patent_app_number] => 12878562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9059444 [patent_doc_number] => 08545879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Fast disintegrating compositions of meloxicam' [patent_app_type] => utility [patent_app_number] => 12/988919 [patent_app_country] => US [patent_app_date] => 2010-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6765 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12988919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371262 [patent_doc_number] => 20120220651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'DESFERRIOXAMINE-METAL COMPLEXES FOR THE TREATMENT OF IMMUNE-RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/390838 [patent_app_country] => US [patent_app_date] => 2010-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 37401 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6008009 [patent_doc_number] => 20110060040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'USES OF ACYLOXYALKYL CARBAMATE PRODRUGS OF TRANEXAMIC ACID' [patent_app_type] => utility [patent_app_number] => 12/858401 [patent_app_country] => US [patent_app_date] => 2010-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13753 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20110060040.pdf [firstpage_image] =>[orig_patent_app_number] => 12858401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039481 [patent_doc_number] => 20110092530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Cyclopamine tartrate salt and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/806271 [patent_app_country] => US [patent_app_date] => 2010-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5480 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092530.pdf [firstpage_image] =>[orig_patent_app_number] => 12806271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6263449 [patent_doc_number] => 20100297263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'COLON CLEANSING COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/852473 [patent_app_country] => US [patent_app_date] => 2010-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16447 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297263.pdf [firstpage_image] =>[orig_patent_app_number] => 12852473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5978316 [patent_doc_number] => 20110071219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'Hemostatic Effects of Glucono-Delta-Lactone' [patent_app_type] => utility [patent_app_number] => 12/851041 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8230 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071219.pdf [firstpage_image] =>[orig_patent_app_number] => 12851041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8221791 [patent_doc_number] => 20120135995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'FUNGICIDAL DIPHENYL-SUBSTITUTED PYRIDAZINES' [patent_app_type] => utility [patent_app_number] => 13/389265 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27085 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757000 [patent_doc_number] => 20120029001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'METHOD OF TREATMENT OF NEPHROGENIC DIABETES INSIPIDUS' [patent_app_type] => utility [patent_app_number] => 12/847553 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1858 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029001.pdf [firstpage_image] =>[orig_patent_app_number] => 12847553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6352646 [patent_doc_number] => 20100331382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'PROCESSES OF MAKING AND USING PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/840505 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5686 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331382.pdf [firstpage_image] =>[orig_patent_app_number] => 12840505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8375394 [patent_doc_number] => 08258186 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-04 [patent_title] => 'Pharmaceutical for oral delivery comprising MGBG' [patent_app_type] => utility [patent_app_number] => 12/837753 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38299 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12837753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8302045 [patent_doc_number] => 20120184604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'COMPOSITION FOR THE PREVENTION OR TREATMENT OF BONE DISEASES COMPRISING COLFORSIN DAROPATE' [patent_app_type] => utility [patent_app_number] => 13/384560 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4405 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384560 [rel_patent_id] =>[rel_patent_doc_number] =>)